Related Experiment Videos

Pheochromocytoma in childhood

E W Fonkalsrud1

  • 1Division of Pediatric Surgery, UCLA School of Medicine 90024.

Progress in Pediatric Surgery
|January 1, 1991
PubMed

Insights

Pediatric pheochromocytomas are rare tumors causing hypertension in children. Surgical removal is now safer, with a mortality rate under 3%, due to improved preoperative management.

Area of Science:

  • Pediatric Endocrinology
  • Surgical Oncology
  • Pediatric Hypertension

Background:

  • Pheochromocytomas are rare neuroendocrine tumors originating from chromaffin cells.
  • In children, these tumors account for 1% of hypertension cases and often present as bilateral, multiple, or extra-adrenal.
  • Malignancy is infrequent in pediatric pheochromocytomas.

Purpose of the Study:

  • To review the characteristics and management of pediatric pheochromocytomas.
  • To highlight advancements in surgical outcomes for this rare condition.

Main Methods:

  • Review of clinical presentation, diagnostic approaches, and treatment strategies for pediatric pheochromocytomas.
  • Analysis of surgical outcomes and complications, particularly focusing on preoperative management and surgical approaches.

Main Results:

  • Children with pheochromocytomas frequently exhibit bilateral, multiple, or extra-adrenal tumors.
  • Preoperative administration of alpha- and beta-blocking agents has significantly reduced surgical complications.
  • Transabdominal resection is the preferred surgical approach due to tumor characteristics in children.
  • The current mortality rate for pheochromocytoma removal in children is less than 3%.

Conclusions:

  • Pheochromocytomas in children, while uncommon, require specific management considerations.
  • Multidisciplinary care involving endocrinologists and surgeons is crucial for optimal outcomes.
  • Advances in medical and surgical management have dramatically improved the safety and success of tumor resection.

Related Concept Videos